You're reading: New York Times: Johnson & Johnson seeks FDA authorization for its booster shot

New York Times: Johnson & Johnson seeks FDA authorization for its booster shot

By New York Times.

Published Oct. 6, 2021 at 2:46 am

In this file photo taken on May 7, 2021 Johnson&Johnson COVID-19 vaccines are seen on a table at a vaccination clinic in Los Angeles.

Photo by AFP

Johnson & Johnson on Tuesday morning asked federal regulators to authorize a booster shot for adults, becoming the third coronavirus vaccine manufacturer to do so. The company said that a second shot of its vaccine about two months after the first significantly boosts protection, to 94 percent, against moderate to severe disease.